Top Markets
#1 B3 (Base) B3 (Base) +68.61%
#2 Chainbase Chainbase +49.84%
#3 Stargate Finance Stargate Finance +25.33%
#4 Kyber Network Crystal Kyber Network Crystal +23.06%
#5 Liquid Mercury Liquid Mercury +20.08%
#6 Block Street Block Street +16.15%
#7 Trusta AI Trusta AI +12.43%
#8 BabyBoomToken BabyBoomToken +11.40%
#9 PlaysOut PlaysOut +10.18%
#10 MEMEX Token MEMEX Token +9.89%
Coin of the day
B3 (Base) B3 (Base)
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
Bristol-Myers Squibb Company Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

BMY
शेयरों में रैंक #149
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and... Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a protein-bound chemotherapy product; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; and Empliciti for the treatment of multiple myeloma. In addition, the company offers Zeposia to treat relapsing forms of multiple sclerosis; Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Inrebic, an oral kinase inhibitor indicated for the treatment of adult patients with myelofibrosis; and Onureg for the treatment of adult patients with AML. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.
शेयर मूल्य
$59.43
मार्केट कैप
$121.03B
बदलाव (1 दिन)
0.83%
बदलाव (1 वर्ष)
0.90%
देश
US
व्यापार Bristol-Myers Squibb Company (BMY)

श्रेणी

Healthcare
Bristol-Myers Squibb Company (BMY) के लिए राजस्व
Dec 2025 में राजस्व TTM: $48.19B
Bristol-Myers Squibb Company की नवीनतम वित्तीय रिपोर्टों के अनुसार, कंपनी की वर्तमान राजस्व (TTM) $48.19B है। 2024 में, कंपनी ने $48.30B का राजस्व अर्जित किया जो 2023 के $45.01B के राजस्व से की वृद्धि है। राजस्व वह कुल आय है जो कंपनी अपने उत्पादों या सेवाओं की बिक्री से उत्पन्न करती है। लाभ की तुलना में इसमें कोई खर्च घटाया नहीं जाता।
Bristol-Myers Squibb Company के लिए 2000 से 2026 तक की राजस्व इतिहास
प्रत्येक वर्ष के अंत में राजस्व
वर्ष राजस्व परिवर्तन
2026 (TTM) $48.19B 0.00%
2025 $48.19B -0.22%
2024 $48.30B 7.32%
2023 $45.01B -2.50%
2022 $46.16B -0.49%
2021 $46.39B 9.09%
2020 $42.52B 62.62%
2019 $26.15B 15.89%
2018 $22.56B 8.59%
2017 $20.78B 6.94%
2016 $19.43B 17.31%
2015 $16.56B 4.29%
2014 $15.88B -3.09%
2013 $16.39B -7.01%
2012 $17.62B -17.05%
2011 $21.24B 9.03%
2010 $19.48B 3.59%
2009 $18.81B -8.69%
2008 $20.60B 6.46%
2007 $19.35B 8.00%
2006 $17.91B -6.73%
2005 $19.21B -0.89%
2004 $19.38B -7.25%
2003 $20.89B 15.32%
2002 $18.12B -6.71%
2001 $19.42B 6.63%
2000 $18.22B 0.00%
समान कंपनियों या प्रतिस्पर्धियों के लिए राजस्व
कंपनी राजस्व राजस्व में अंतर देश
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
 $65.18B 35.24%
US
AstraZeneca PLC AstraZeneca PLC
AstraZeneca PLC
AZN.US
 $58.74B 21.88%
GB
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $94.19B 95.45%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $61.16B 26.90%
US
Novartis AG Novartis AG
Novartis AG
NVS.US
 $56.15B 16.51%
CH